| Financial Year |
March 31 2023 |
| Monetary Funds |
6,199,121,582.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
53,000,000.00 |
| Accounts Receivable |
1,473,866,158.86 |
| Advances to Suppliers |
438,834,768.68 |
| Other Receivables |
27,999,566.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,730,000.00 |
| Inventories |
736,188,857.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
35,069,297.86 |
| Total Current Assets |
9,239,885,927.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
13,088,720.00 |
| Long-term Equity Investment |
770,169,068.73 |
| Investment Properties |
8,047,190.05 |
| Fixed Assetes |
17,131,641,706.35 |
| Under-construction Projects |
454,862,655.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,472,654,785.33 |
| R&D expenses |
-- |
| Goodwill |
270,954,007.89 |
| Long-Term Deferred and Prepaid Expenses |
351,283,156.65 |
| Deferred Income Tax Assets |
113,592,181.70 |
| Other Non-Current Assets |
53,632,309.47 |
| Sub-Total of Non-Current Assets |
23,740,029,666.66 |
| Total Assets |
32,979,915,593.70 |
| Short-Term Loans |
4,613,415,046.36 |
| Trading Financial liabilities |
-- |
| Notes Payable |
250,422,023.82 |
| Accounts Payable |
2,171,221,403.90 |
| Accounts Received In Advance |
33,822,566.04 |
| Employee Compensation Payable |
94,685,455.82 |
| Taxes Payable |
443,366,578.71 |
| Interest Payable |
-- |
| Dividend Payable |
8,153,426.58 |
| Other payables |
430,033,147.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,003,479,758.24 |
| Other Current Liabilities |
36,129,128.52 |
| Sub-Total of Current Liabilities |
12,499,540,657.74 |
| Long-term Loans |
7,167,989,684.12 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
5,234,396,399.17 |
| Special Payable |
-- |
| Estimatied Liabilities |
263,622,339.95 |
| Deferred Income Tax Liabilities |
170,499,768.84 |
| Other Non-Current Liabilities |
109,538,933.01 |
| Sub-Total of Non-Current Liabilities |
13,196,933,070.29 |
| Total Liabilities |
25,696,473,728.03 |
| Paid-In Capital(Or Share Stock) |
7,907,336,210.00 |
| Capital Surplus |
217,036,234.17 |
| Surplus Reserve |
125,455,180.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-5,329,483,463.10 |
| Minority Stockholder's Interest |
3,673,646,550.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,609,795,314.70 |
| Owner's Equity（Stockholder's Equity） |
7,283,441,865.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
32,979,915,593.70 |
